|
| Exchange Received Time 15/01/2018 13:06:21 Exchange Disseminated Time 15/01/2018 13:06:24 Time Taken 00:00:03 |
To,
Dy. General Manager,
Department of Corporate Services,
BSE Ltd.,
P. J. Towers, Dalal Street,
Fort, Mumbai - 400 001.
Ref: Scrip Code: 532296
Dear Sirs,
Sub: Glenmark initiates Phase IIb dose range finding study for novel molecule GRC 27864
With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
Request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Glenmark Pharmaceuticals Limited
Harish Kuber
Company Secretary & Compliance Officer
|
|
|